imatinib mesylate has been researched along with Acute Kidney Failure in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (40.00) | 29.6817 |
| 2010's | 7 (46.67) | 24.3611 |
| 2020's | 2 (13.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, C; Li, X; Qi, J; Yongjing, W | 1 |
| Burke, MJ; Egelund, TA; Katzenstein, HM; Liberio, N; Ng, JS; Pommert, L; Siver, MJ | 1 |
| Ahmed, Y; Baufreton, C; Boer, C; de Lange, F; Jongman, RM; Koning, NJ; Niessen, HW; Schwarte, LA; van Meurs, M; van Nieuw Amerongen, GP; Vonk, ABA | 1 |
| Nhiayi, MK; Sridevi, P; Wang, JY | 1 |
| Borthakur, G; Burger, J; Cortes, JE; Ferrajoli, A; Jabbour, E; Kantarjian, H; Lahoti, A; Nogueras-González, GM; O'Brien, S; Pierce, S; Ravandi, F; Yilmaz, M | 1 |
| Al-Kali, A; Farooq, S; Tfayli, A | 1 |
| Haba, Y; Hanzawa, K; Itoyama, S; Kizaki, M; Mori, S; Nemoto, T; Sagawa, M; Saito, Y; Sekiguchi, Y; Tamaru, J; Tokuhira, M; Tomikawa, A; Watanabe, R | 1 |
| Hamada, Y; Ito, I; Ito, Y; Maruyama, S; Masuda, T; Matsuo, S; Mizuno, M; Ozaki, T; Sato, W; Tatematsu, M; Yasuda, Y; Yuzawa, Y | 1 |
| Hever, A; Johnston, WH; Kujubu, DA; Moore, AE; Peng, S | 1 |
| Akkerhuis, KM; Boersma, E; Clementino, NCD; Macedo, AV; Marcolino, MS; Marx-Neto, AD; Ribeiro, AL; Silva, MHCR; van Gelder, T | 1 |
| Botey, A; Cervantes, F; Pou, M; Saurina, A; Saval, N; Solé, M; Vera, M | 1 |
| Fujimoto, M; Fukumot, T; Kuwajima, M; Mano, S; Matsuhashi, Y; Nagai, M; Tamura, T; Tasaka, T | 1 |
| Al Aly, Z; Gellens, ME; González, EA; Philoctête Ashley, JM | 1 |
| Finkel, KW; Foringer, JR; Guntupalli, JS; Samuels, JA; Tjia, VM; Verani, RR | 1 |
| Akdag, I; Ali, R; Ozan, U; Ozcelik, T; Ozkalemkas, F; Ozkan, A; Ozkocaman, V; Tunali, A | 1 |
15 other study(ies) available for imatinib mesylate and Acute Kidney Failure
| Article | Year |
|---|---|
Acute kidney injury and delayed methotrexate clearance in an adult patient with Philadelphia chromosome-positive acute lymphoblastic leukaemia treated with imatinib.
Topics: Acute Kidney Injury; Adult; Female; Humans; Imatinib Mesylate; Methotrexate; Philadelphia Chromosome; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2023 |
Concurrent Imatinib Dosing With High-dose Methotrexate Leads to Acute Kidney Injury and Delayed Methotrexate Clearance in Pediatric Patients With Philadelphia Chromosome-positive B-Cell Acute Lymphoblastic Leukemia.
Topics: Acute Kidney Injury; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Female; Follow-Up Studies; Humans; Imatinib Mesylate; Leukemia, B-Cell; Male; Methotrexate; Philadelphia Chromosome; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Young Adult | 2021 |
Reduction of vascular leakage by imatinib is associated with preserved microcirculatory perfusion and reduced renal injury markers in a rat model of cardiopulmonary bypass.
Topics: Acute Kidney Injury; Animals; Capillary Permeability; Cardiopulmonary Bypass; Cytokines; Disease Models, Animal; Drug Evaluation, Preclinical; Endothelium, Vascular; Imatinib Mesylate; Inflammation Mediators; Male; Microcirculation; Microscopy, Electron; Oxygen Consumption; Premedication; Protein Kinase Inhibitors; Random Allocation; Rats, Wistar | 2018 |
Genetic disruption of Abl nuclear import reduces renal apoptosis in a mouse model of cisplatin-induced nephrotoxicity.
Topics: Acute Kidney Injury; Animals; Apoptosis; Apoptosis Regulatory Proteins; Benzamides; Cisplatin; Disease Models, Animal; Female; Imatinib Mesylate; Kidney Tubules, Proximal; Male; Mice; Mice, Knockout; Mutation; Nuclear Localization Signals; Piperazines; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-abl; Pyrimidines; STAT1 Transcription Factor; Tumor Suppressor Protein p53; Tumor Suppressor Proteins | 2013 |
Estimated glomerular filtration rate changes in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors.
Topics: Acute Kidney Injury; Adolescent; Adult; Aged; Aged, 80 and over; Creatinine; Dasatinib; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Glomerular Filtration Rate; Humans; Imatinib Mesylate; Incidence; Kidney; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrimidines; Renal Insufficiency, Chronic; Retrospective Studies; Treatment Outcome; Young Adult | 2015 |
Tumor lysis syndrome after starting treatment with Gleevec in a patient with chronic myelogenous leukemia.
Topics: Acute Kidney Injury; Aged; Antineoplastic Agents; Benzamides; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Tumor Lysis Syndrome | 2009 |
[Acute-onset eosinophilic leukemia associated with tumor lysis syndrome after imatinib and steroid pulse therapy].
Topics: Acute Kidney Injury; Aged, 80 and over; Benzamides; Disseminated Intravascular Coagulation; Drug Synergism; Fatal Outcome; Female; Humans; Hypereosinophilic Syndrome; Imatinib Mesylate; Leukemia, Eosinophilic, Acute; Methylprednisolone; Piperazines; Pleural Effusion; Pulse Therapy, Drug; Pyrimidines; Tumor Lysis Syndrome | 2010 |
Acute kidney injury presenting a feature of leukemic infiltration during therapy for chronic myelogenous leukemia.
Topics: Acute Kidney Injury; Aged, 80 and over; Benzamides; Diagnosis, Differential; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemic Infiltration; Male; Piperazines; Pyrimidines | 2010 |
Systemic mastocytosis presenting with acute oliguric renal failure: report of a case and review of the literature.
Topics: Acute Kidney Injury; Antineoplastic Agents; Benzamides; Biopsy; Bone Marrow; Diagnosis, Differential; Fatal Outcome; Female; Follow-Up Studies; Humans; Imatinib Mesylate; Kidney; Mastocytosis, Systemic; Middle Aged; Oliguria; Piperazines; Protein-Tyrosine Kinases; Pyrimidines | 2012 |
Imatinib treatment duration is related to decreased estimated glomerular filtration rate in chronic myeloid leukemia patients.
Topics: Acute Kidney Injury; Adult; Age Factors; Antineoplastic Agents; Benzamides; Creatinine; Female; Glomerular Filtration Rate; Humans; Imatinib Mesylate; Kidney Failure, Chronic; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Piperazines; Pyrimidines; Young Adult | 2011 |
Acute renal failure secondary to imatinib mesylate treatment in chronic myeloid leukemia.
Topics: Acute Kidney Injury; Antineoplastic Agents; Benzamides; Enzyme Inhibitors; Female; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Middle Aged; Piperazines; Protein-Tyrosine Kinases; Pyrimidines | 2003 |
Massive bone marrow necrosis in a patient with chronic myelocytic leukemia following imatinib mesylate therapy.
Topics: Acute Kidney Injury; Antineoplastic Agents; Benzamides; Bone Marrow; Disseminated Intravascular Coagulation; Fatal Outcome; Female; Fusion Proteins, bcr-abl; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Middle Aged; Necrosis; Neoplasm Proteins; Piperazines; Pneumonia; Protein Kinase Inhibitors; Pyrimidines | 2004 |
Thrombotic thrombocytopenic purpura in a patient treated with imatinib mesylate: true association or mere coincidence?
Topics: Acute Kidney Injury; Adult; Benzamides; Combined Modality Therapy; Female; Fever of Unknown Origin; Humans; Hypereosinophilic Syndrome; Imatinib Mesylate; Immunosuppressive Agents; Lymphatic Diseases; Piperazines; Plasma Exchange; Purpura, Thrombotic Thrombocytopenic; Pyrimidines; Renal Dialysis; Retinal Artery Occlusion | 2005 |
Acute renal failure secondary to imatinib mesylate treatment in prostate cancer.
Topics: Acute Kidney Injury; Benzamides; Humans; Imatinib Mesylate; Kidney; Kidney Function Tests; Male; Middle Aged; Piperazines; Prostatic Neoplasms; Protein Kinase Inhibitors; Pyrimidines; Renal Dialysis | 2005 |
Tumour lysis syndrome with acute renal failure during imatinib therapy.
Topics: Acute Kidney Injury; Antineoplastic Agents; Benzamides; Humans; Imatinib Mesylate; Kidney Neoplasms; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Piperazines; Protein-Tyrosine Kinases; Pyrimidines; Tumor Lysis Syndrome | 2007 |